Skip to content
Wholesale trade
KZActiveBIN 060140014310
Plans from 2 000 ₸ a month
No entries in risk registers
Registers checked: 17
To risks

ТОО "АЛЕМ-ФАРМ-05"

Director
Агыбаев Жамалбек Жанабаевич
Incorporated
20.01.2006
Address
Шымкент ул. БЕЙБИТШИЛИК, 20, кв. 35
РНН
582100255229

This is a company preview

Unlock the full report for 1 check — contacts, bank accounts, court cases, government contracts, arrests, licenses and PDF export.

The pack is not a subscription, its checks last 30 days

Risks

0/17

This assessment is informational and analytical only, based on our internal methodology and open sources; it is not an official government conclusion or a guarantee of reliability.

Procurement signals

Court cases

Arrests & encumbrances

Enforcement proceedings

Certificates

Licenses

Profile

Summary

Full name
ТОВАРИЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "АЛЕМ-ФАРМ-05"
BIN
060140014310
Status
Active
Director
Агыбаев Жамалбек Жанабаевич
Registration date
20.01.2006
Activity
Оптовая торговля фармацевтическими товарами, кроме торговли медицинской техникой и ортопедическими изделиями
Legal address
Шымкент ул. БЕЙБИТШИЛИК, 20, кв. 35

In government contracts over 2 years

  • г.Шымкент, Абайский район, Бейбитшилик, 20, 35 matches the registered one

    contract of 22.07.2025
VAT payer
Yes, since 01.05.2006
КАТО
791910000
РНН
582100255229
КФС
Собственность предприятий без государственного и иностранного участия
КСЕ
Национальные частные нефинансовые корпорации – ОПП
Company size
Малые предприятия
Employees
от 0 до 5 чел.
Procurement role
Поставщик

Activities

1
46461primary

Оптовая торговля фармацевтическими товарами, кроме торговли медицинской техникой и ортопедическими изделиями

Download

Contacts

Change history

Financials

Tax payments

6

By year · ₸

2026
1.4M
2025
2.3M+56%
2024
1.5M-22%
2023
1.9M+42%
2022
1.3M+622%
2021
186.9K
·1.4M
2026year to date
+56%2.3M
2025
-22%1.5M
2024
+42%1.9M
2023
+622%1.3M
2022
·186.9K
2021
2026
Tax paid1,361,060 ₸
Penalty2,350 ₸
Fine0 ₸
VAT refund0 ₸
2025
Tax paid2,336,306 ₸
Penalty1,550 ₸
Fine0 ₸
VAT refund0 ₸
2024
Tax paid1,495,850 ₸
Penalty0 ₸
Fine0 ₸
VAT refund0 ₸
2023
Tax paid1,916,223 ₸
Penalty0 ₸
Fine0 ₸
VAT refund0 ₸
2022
Tax paid1,349,879 ₸
Penalty46,400 ₸
Fine0 ₸
VAT refund0 ₸
2021
Tax paid186,924 ₸
Penalty0 ₸
Fine0 ₸
VAT refund0 ₸
Estimated taxable profit

Estimate: corporate income tax ÷ 0%. Not a filing and not revenue — the taxable profit implied by the corporate income tax paid. Actual profit differs by deductions, carried-forward losses and reduced rates.

Download

Financial statements

Premium

Public contracts

What it sells and where

Samruk-Kazyna procurement

Tender bids

Procurement as a customer

Assets

Bank accounts

Management & owners

Leadership

1
  • АЖ

    Агыбаев Жамалбек Жанабаевич

    Director

Download

Founders

Accreditations

Employees

Affiliated companies

Premium

Director's involvement in other legal entities

Branches

Relations & mentions

Company networks

Premium

Similar companies

Media mentions

Company summary

ТОО "АЛЕМ-ФАРМ-05" (BIN 060140014310) is an active legal entity in Шымкент, registered in 2006 (20 years on the market). Primary activity — оптовая торговля фармацевтическими товарами, кроме торговли медицинской техникой и ортопедическими изделиями. Per open government registries as of November 7, 2026: 20 government contracts on Портал государственных закупок РК (goszakup.gov.kz) worth 64,432,616 ₸. Automated screening of open registries found no risk indicators for "АЛЕМ-ФАРМ-05". Director on record — Агыбаев Жамалбек Жанабаевич. Data current as of November 7, 2026.

Information is aggregated from open government registries of Kazakhstan: Министерство юстиции РК, Комитет государственных доходов МФ РК, Верховный Суд РК, Портал государственных закупок РК, АО «Самрук-Казына», Бюро национальной статистики РК, Портал электронного лицензирования. Data is indexed automatically and may lag behind primary sources; the absence of a record does not guarantee the absence of the corresponding facts. This is reference information and does not replace an official extract. Learn more about the methodology and sources — SafeDeal editorial policy.